| 生物活性 | |||
|---|---|---|---|
| 描述 | Encequidar demonstrates comparable potency to the reference Pgp inhibitor tariquidar in blocking rhodamine 123 efflux from CCRF-CEM T cells (IC50, tariquidar: 8.2±2.0 nM, Encequidar: 13.1±2.3 nM) [1]. Encequidar (HM30181) exhibits high selectivity for mP-gp, with a potency 20-50 times greater than that of tariquidar, another third-generation P-gp inhibitor[2]. | ||
| 实验方案 | |||
|---|---|---|---|
| 1mg | 5mg | 10mg | |
|
1 mM 5 mM 10 mM |
1.45mL 0.29mL 0.15mL |
7.26mL 1.45mL 0.73mL |
14.52mL 2.90mL 1.45mL |
| 参考文献 |
|---|